Evotec

Evotec and Janssen team up to develop immune-based therapies

30-Jan-2023 By Rachel Arthur

Evotec has entered into a strategic collaboration and licence agreement with Janssen Biotech: with the partnership focusing on developing targeted immune-based therapies for oncology.

Evotec breaks ground on Toulouse biologics manufacturing facility

19-Sep-2022 By Rachel Arthur

Evotec SE has officially launched the construction of its J.POD biologics manufacturing facility at its Campus Curie in Toulouse, France.

Evotec expands cell therapy manufacturing with acquisition

31-May-2022 By Ben Hargreaves

Evotec agrees to acquire Rigenerand, which adds a manufacturing facility capable of producing cell therapies to its infrastructure in Italy.

Can Sernova and Evotec’s cell therapy approach result in a functional cure for diabetes?

19-May-2022 By Jane Byrne

Sernova and Evotec are teaming up on an implantable beta cell replacement therapy to replace insulin injections for the millions of patients with diabetes.

Takeda expands in gene therapy with $900m R&D deal

02-Jul-2020 By Ben Hargreaves

Takeda signs R&D agreement with Carmine for the development of two non-viral gene therapies.

Takeda taps Evotec for gene therapy discovery

14-Apr-2020 By Ben Hargreaves

Looking to expand its pipeline of gene therapies, Takeda announces a long-term research partnership with Evotec.

Evotec jumps into biologics through $90m Just.Bio acquisition

29-May-2019 By Vassia Barba

Evotec to join the emerging biologics market through Just Biotherapeutics’ smart technology platforms, machine learning tools and low cost manufacturing facilities.

Evotec expands ADMET platform, EVOprofile

10-May-2004

The company Evotec OAI, a drug discovery and development solution
provider to the pharmaceutical and biotechnology industries has
announced the successful expansion of their in vitro and in silico
ADMET (Adsorption, Distribution,...